Uncategorized

Recent stock market bids and deals seem to have made it easier for troubled Kiwi building products giant, Fletcher Building (ASX:FBU), to convince big investors to contribute to the $NZ700 million capital raising, which had the feel of an emergency round to help the company survive. The company aimed to raise $NZ282 million from investment […]

China’s central bank has implemented yet another minor market rate cut that will have no significant impact on the economy’s sluggish growth. The cut in a key short-term policy rate and the injection of additional liquidity into the financial system came as a surprise on Monday morning, after the bank left more prominent one- and

Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the company’s latest results in head and neck cancer. Peter Milios: I’m Peter Milios from the Finance News Network, and today we’re talking with Immutep (ASX:IMM). Immutep is trading under the ASX code “IMM” and has a market capitalisation of approximately $487m. Immutep is a

Amplia Therapeutics (ASX:ATX) announced that its Phase 2a clinical trial, known as the ACCENT trial, is continuing enrolment for narmafotinib in the treatment of advanced pancreatic cancer. Six out of 16 patients assessed have shown confirmed partial responses (PRs). Shares are trading 14.81 per cent higher at 15.5 cents. Wellard (ASX:WLD) has secured full ownership

The Australian sharemarket experienced a decline from record highs, primarily due to investor concerns regarding the Reserve Bank’s potential delay in interest rate cuts, expected to remain steady at 4.35 per cent for the seventh consecutive meeting. At 11:40am, the S&P/ASX 200 is 0.68 per cent lower at 8,153.90. Consumer stocks suffer the most following

For months now, major retail chains Woolworths (ASX:WOW) and Coles (ASX:COL), along with business groups, media, and analysts, have denied any allegations of price gouging occurring in supermarkets. These allegations received a boost from a move revealed on Monday by the competition and consumer watchdog, the ACCC, which has accused Woolworths and Coles of misleading

Trans-Tasman building products giant Fletcher Building (ASX:FBU) has confirmed weekend reports that it is looking to raise NZ$700 million (A$641 million) to reduce debt and provide greater financial stability. It plans to raise NZ$282 million from investment funds and NZ$418 million from current shareholders. The company has entered a trading halt on both sides of

The Dow Jones Industrial Average recorded a modest gain, closing at a record high on Friday, marking a significant rally for the week following the Federal Reserve’s first major easing of interest rate policy in four years. The 30-stock Dow rose by 38.17 points, or 0.09 per cent, reaching a new closing high of 42,063.36.

A dirty finish for Wall Street on Friday saw a gain for the day for the Dow and a record, but small blobs of red ink for the S&P 500 and Nasdaq as more investors took a long look at the economy and the Fed’s rate cut, pondering whether there was a deeper message there.

UK property listings and services company Rightmove has said “no” for a second time to a new non-binding offer from News Corp’s REA Group (ASX:REA). Media reports on Monday stated that Rightmove rejected the sweetened takeover bid from REA, which valued the company at around $11.5 billion. The Financial Times reported that the new offer